Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy Endpoint Standardization in Adult Primary CNS Tumor Trials: Integrating Regulatory Science and Clinical Perspectives in the RANO 2.0 Era.

Cancers·2026
Same author

Possible involvement of genome-wide near-haploidy and <i>MEN1</i> mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing.

Neuro-oncology advances·2026
Same author

A response to the letter regarding "<i>Minimally invasive surgery for remnant gastric cancer: a single-center retrospective study of treatment outcomes in Japan</i>".

Journal of minimally invasive surgery·2026
Same author

Association between time to surgery and survival in patients with initially diagnosed WHO 2021 grade 4 gliomas.

Neuro-oncology advances·2026
Same author

Rare Case of a Cervical Ventral Root Filament Neuroma Mimicking a Sequestrated Disc Herniation in Association with Ossification of the Posterior Longitudinal Ligament.

NMC case report journal·2026
Same author

Laminaran Attenuates NaCl-Induced Cytotoxicity via ROS Scavenging and Prevents Alteration of Cellular Elastic Modulus.

Marine drugs·2026

Related Experiment Video

Updated: May 1, 2026

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.6K

Radiodynamic Therapy for High-Grade Glioma in Normoxic and Hypoxic Environments for High-Grade Glioma.

Erika Yamada1, Eiichi Ishikawa1,2, Tsubasa Miyazaki3

  • 1Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Tsukuba 305-8576, Japan.

Cancers
|December 30, 2025
PubMed
Summary

Radiodynamic therapy (RDT) combining 5-aminolevulinic acid (5-ALA) and X-ray irradiation shows promise for high-grade glioma (HGG) under normoxia. Hypoxia limits RDT efficacy but may inhibit angiogenesis, warranting further research.

Keywords:
5-ALAgliomahypoxiaimmune reactionradiodynamic therapy

More Related Videos

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

Related Experiment Videos

Last Updated: May 1, 2026

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.6K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K

Area of Science:

  • Oncology
  • Radiotherapy
  • Molecular Biology

Background:

  • High-grade glioma (HGG) presents therapeutic challenges.
  • Radiodynamic therapy (RDT), combining 5-aminolevulinic acid (5-ALA) and X-ray irradiation, is explored for HGG.
  • Understanding RDT efficacy across oxygen levels and its impact on the tumor microenvironment is crucial.

Purpose of the Study:

  • To evaluate the therapeutic potential of RDT for high-grade glioma (HGG).
  • To investigate RDT efficacy in normoxic and hypoxic conditions.
  • To elucidate RDT's mechanisms and effects on the tumor micro-immune environment.

Main Methods:

  • Experiments utilized human glioma cell lines (U87MG, U251MG) in vitro.
  • Cells were treated with or without 5-aminolevulinic acid (5-ALA) and X-ray irradiation.
  • Experiments were conducted under normoxic (20% O2) and hypoxic (3% O2) conditions.

Main Results:

  • RDT significantly reduced U87MG cell viability under normoxia via increased reactive oxygen species (ROS) production.
  • RDT efficacy was diminished under hypoxic conditions.
  • RDT modulated immune-related gene expression, epithelial-mesenchymal transition (EMT) genes, soluble PD-L1, VEGF, and CSF-1 secretion depending on oxygen levels.

Conclusions:

  • RDT, combining 5-ALA and X-ray irradiation, demonstrates therapeutic potential for HGG, particularly under normoxic conditions.
  • RDT may offer benefits under hypoxia, notably in inhibiting angiogenesis.
  • Oxygen levels critically influence RDT efficacy and its impact on the tumor microenvironment, necessitating further research for clinical optimization.